Literature DB >> 24314666

Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer.

Alyce A Chen1, Daniëlle A M Heideman, Debby Boon, Zigui Chen, Robert D Burk, Hugo De Vuyst, Tarik Gheit, Peter J F Snijders, Massimo Tommasino, Silvia Franceschi, Gary M Clifford.   

Abstract

Human papillomavirus (HPV) 33, a member of the HPV16-related alpha-9 species group, is found in approximately 5% of cervical cancers worldwide. The current study aimed to characterize the genetic diversity of HPV33 and to explore the association of HPV33 variants with the risk for cervical cancer. Taking advantage of the International Agency for Research on Cancer biobank, we sequenced the entire E6 and E7 open reading frames of 213 HPV33-positive cervical samples from 30 countries. We identified 28 HPV33 variants that formed 5 phylogenetic groups: the previously identified A1, A2, and B (sub)lineages and the novel A3 and C (sub)lineages. The A1 sublineage was strongly over-represented in cervical cases compared to controls in both Africa and Europe. In conclusion, we provide a classification system for HPV33 variants based on the sequence of E6 and E7 and suggest that the association of HPV33 with cervical cancer may differ by variant (sub)lineage.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; HPV; Phylogeny; Variants

Mesh:

Substances:

Year:  2013        PMID: 24314666      PMCID: PMC3984975          DOI: 10.1016/j.virol.2013.10.033

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  47 in total

1.  A review of human carcinogens--Part B: biological agents.

Authors:  Véronique Bouvard; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2009-04       Impact factor: 41.316

2.  Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes.

Authors:  I Zehbe; R Tachezy; J Mytilineos; G Voglino; I Mikyskova; H Delius; A Marongiu; L Gissmann; E Wilander; M Tommasino
Journal:  Int J Cancer       Date:  2001-12-01       Impact factor: 7.396

3.  Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia.

Authors:  Eda Vrtačnik Bokal; Boštjan J Kocjan; Mario Poljak; Zeljka Bogovac; Nina Jančar
Journal:  J Obstet Gynaecol Res       Date:  2010-12       Impact factor: 1.730

4.  Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.

Authors:  G M Clifford; S Gallus; R Herrero; N Muñoz; P J F Snijders; S Vaccarella; P T H Anh; C Ferreccio; N T Hieu; E Matos; M Molano; R Rajkumar; G Ronco; S de Sanjosé; H R Shin; S Sukvirach; J O Thomas; S Tunsakul; C J L M Meijer; S Franceschi
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

5.  Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR.

Authors:  Iris Cornet; Tarik Gheit; Silvia Franceschi; Jerome Vignat; Robert D Burk; Bakary S Sylla; Massimo Tommasino; Gary M Clifford
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

6.  Persistence and clearance of human papillomavirus infection: a prospective cohort study.

Authors:  Maria Inês Rosa; Jandira M G Fachel; Daniela D Rosa; Lidia R Medeiros; Cristine N Igansi; Mary C Bozzetti
Journal:  Am J Obstet Gynecol       Date:  2008-09-16       Impact factor: 8.661

7.  Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland.

Authors:  A Bardin; S Vaccarella; G M Clifford; J Lissowska; M Rekosz; P Bobkiewicz; J Kupryjańczyk; R Krynicki; J Jonska-Gmyrek; A Danska-Bidzinska; P J F Snijders; C J L M Meijer; W Zatonski; S Franceschi
Journal:  Eur J Cancer       Date:  2008-01-11       Impact factor: 9.162

8.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

Review 9.  Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  BMC Infect Dis       Date:  2009-07-29       Impact factor: 3.090

10.  HPV infection in women with and without cervical cancer in Conakry, Guinea.

Authors:  N Keita; G M Clifford; M Koulibaly; K Douno; I Kabba; M Haba; B S Sylla; F J van Kemenade; P J F Snijders; C J L M Meijer; S Franceschi
Journal:  Br J Cancer       Date:  2009-06-16       Impact factor: 7.640

View more
  12 in total

1.  Human papillomavirus 45 genetic variation and cervical cancer risk worldwide.

Authors:  Alyce A Chen; Daniëlle A M Heideman; Debby Boon; Tarik Gheit; Peter J F Snijders; Massimo Tommasino; Silvia Franceschi; Gary M Clifford
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

2.  Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia.

Authors:  Long Fu Xi; Mark Schiffman; Laura A Koutsky; James P Hughes; Rachel L Winer; Constance Mao; Ayaka Hulbert; Shu-Kuang Lee; Zhenping Shen; Nancy B Kiviat
Journal:  J Natl Cancer Inst       Date:  2014-09-13       Impact factor: 13.506

3.  Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.

Authors:  Anna Godi; Dolcibella Boampong; Busayo Elegunde; Kavita Panwar; Maxime Fleury; Shaowei Li; Qinjian Zhao; Ningshao Xia; Neil D Christensen; Simon Beddows
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

4.  Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide.

Authors:  Alyce A Chen; Tarik Gheit; Silvia Franceschi; Massimo Tommasino; Gary M Clifford
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

5.  E6 and E7 Gene Polymorphisms in Human Papillomavirus Types-58 and 33 Identified in Southwest China.

Authors:  Zuyi Chen; Yaling Jing; Qiang Wen; Xianping Ding; Tao Wang; Xuemei Mu; Yuwei Chenzhang; Man Cao
Journal:  PLoS One       Date:  2017-01-31       Impact factor: 3.240

Review 6.  Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation.

Authors:  Arnaud John Kombe Kombe; Bofeng Li; Ayesha Zahid; Hylemariam Mihiretie Mengist; Guy-Armel Bounda; Ying Zhou; Tengchuan Jin
Journal:  Front Public Health       Date:  2021-01-20

7.  HPV genotype distribution and anomalous association of HPV33 to cervical neoplastic lesions in San Luis Potosí, Mexico.

Authors:  Raúl DelaRosa-Martínez; Mireya Sánchez-Garza; Rubén López-Revilla
Journal:  Infect Agent Cancer       Date:  2016-03-30       Impact factor: 2.965

8.  Human papillomavirus variants among Inuit women in northern Quebec, Canada.

Authors:  Barbara Gauthier; Francois Coutlée; Eduardo L Franco; Paul Brassard
Journal:  Int J Circumpolar Health       Date:  2015-12-09       Impact factor: 1.228

9.  L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis.

Authors:  Zuyi Chen; Yaling Jing; Qiang Wen; Xianping Ding; Shun Zhang; Tao Wang; Yiwen Zhang; Jianhui Zhang
Journal:  Virol J       Date:  2016-10-07       Impact factor: 4.099

10.  Phylogeny and polymorphism in the E6 and E7 of human papillomavirus: alpha-9 (HPV16, 31, 33, 52, 58), alpha-5 (HPV51), alpha-6 (HPV53, 66), alpha-7 (HPV18, 39, 59, 68) and alpha-10 (HPV6, 44) in women from Shanghai.

Authors:  Junwei Zhao; Qin Zhan; Junhan Guo; Min Liu; Yetian Ruan; Tailin Zhu; Lingfei Han; Fang Li
Journal:  Infect Agent Cancer       Date:  2019-11-21       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.